CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib in combination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia.
Author
Adeboye H. Adewoye
Bipinkumar R. Amin
+7Â more
Gilles A. Salles
Michelle Wong
Muhammad-Ali A. Zaydan
Nashat Y. Gabrail
Nicole Lamanna
Paolo Ghia
Ralph V. Boccia
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study
Author
Alfred Saleh
Amanda F. Cashen
+19Â more
Bipinkumar Amin
Blum KA
Brad S. Kahl
Bruce D. Cheson
Forstpointner R
Hongliang Shi
Hrusovsky I
Jeffrey Letzer
Jeffrey V. Matous
Kahl BS
Ma MH
Michael E. Williams
Nathan Fowler
Orlowski RZ
Peter Lee
Peter Rosen
Samuel A. Jacobs
Sonali Smith
Sudha Parasuraman
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref